Skip to main content

Day: June 4, 2020

SigmaTron and Wagz Announce Letter of Intent for Merger Transaction

ELK GROVE VILLAGE, Ill. and PORTSMOUTH, N.H., June 04, 2020 (GLOBE NEWSWIRE) — SigmaTron International, Inc. (NASDAQ: SGMA), (“SigmaTron”) an electronic manufacturing services company, and Wagz Inc. (“Wagz”), a privately held Pet Technology(“Pet Tech”) company, today announced that they have executed a Letter of Intent (“LOI”) relating to a proposed business combination.  Subject to the terms and conditions set forth in the LOI, SigmaTron would issue approximately 2,270,000 new shares of SigmaTron stock that would result in the Stockholders of Wagz owning approximately one-third of the combined company.  The expectation is that the deal will be closed by the end of August 2020 and it remains subject to achievement of certain milestones and satisfaction of conditions by both parties prior to closing such as finalizing a material definitive...

Continue reading

COSTCO AUTO PROGRAM EXCLUSIVE INCENTIVES ON VOLVO SUVS AND WAGONS

San Diego, June 04, 2020 (GLOBE NEWSWIRE) — Costco Auto Program now provides exclusive incentives to Costco members on Volvo luxury SUVs and wagons starting at $1,250 off an eligible purchase or lease. Among the models offered during the Volvo Limited-Time Special is the award-winning 2020 Volvo XC40. According to Costco Auto Program, operated by Affinity Auto Program, the XC40 is the most requested small premium SUV by Costco members. The Volvo XC90, also available during this limited-time event, is among the top three midsize premium SUVs that Costco members often request. “Volvo Cars’ range of award-winning SUVs and wagons are some of the safest, technologically advanced and stylish vehicles in their category,” said Rick Bryant, Vice President of Sales Operations Volvo Car USA. “The Costco Auto Program will make them a better...

Continue reading

Aegion Corporation to Present at the Stifel 2020 Virtual Cross Sector Insight Conference

ST. LOUIS, June 04, 2020 (GLOBE NEWSWIRE) — Aegion Corporation (NASDAQ: AEGN) announced today its President and CEO, Charles R. Gordon, will participate in a fireside chat at the Stifel 2020 Virtual Cross Sector Insight Conference on Wednesday, June 10, 2020. A live webcast of Mr. Gordon’s discussion is scheduled to occur at approximately 2:00 p.m. Eastern Time. Mr. Gordon, as well as David F. Morris, Executive Vice President and CFO, will also host virtual meetings with institutional investors as part of the conference participation.The fireside chat webcast and any accompanying materials will be available through Aegion’s website at www.aegion.com/investor/financial-news-resources/webcasts.About Aegion Corporation (NASDAQ: AEGN) Aegion combines innovative technologies with market-leading expertise to maintain, rehabilitate and...

Continue reading

Atos co-founds GAIA-X to build a secure and transparent European data and cloud framework

Paris, 4 June 2020 – Atos, a global leader in digital transformation, is proud to announce its role as a founding member of the GAIA-X Foundation, a non-profit organization that is being setup to create the next generation of data platforms for Europe, its member states, companies and citizens.The GAIA-X Foundation, formed by 22 organizations (digital leaders, industrials, academia and associations) including Atos, underlines a joint commitment to a transparent European process, openness and broad participation. It will build on the existing work initiated by the French and German governments and supported by more than 300 businesses. The GAIA-X project enters a new stage of its development and sets an important milestone toward the European Union’s ambition to consolidate its leadership in the global data economy.The creation of digital...

Continue reading

Atos participe à la création de GAIA-X pour favoriser l’usage du Cloud et le partage des données dans un cadre européen sécurisé et transparent

Paris, le 4 juin 2020 – Atos, leader international de la transformation digitale, est fier d’annoncer son rôle de membre fondateur de la Fondation GAIA-X, une organisation à but non lucratif visant à créer la prochaine génération de plateformes de données pour l’Europe, ses États membres, entreprises et citoyens.La Fondation GAIA-X, formée par 22 organisations (leaders du digital, industriels, universitaires et associations) dont Atos, souligne leur engagement en faveur d’un processus européen reposant sur la transparence et l’ouverture, mobilisant autant d’acteurs que possible. Elle s’appuiera sur les travaux existants initiés par les gouvernements français et allemand, également soutenus par plus de 300 entreprises. Le projet GAIA-X entre désormais dans une nouvelle phase de son développement et permet...

Continue reading

View Systems, Inc.’s (VSYM) Sannabis Launches Tele-Health Portal Offering Virtual Appointments to Patients Around the World to Buy their Health Authority Registered Products.

Dr. Sannabis to assist thousands of customers formulate and drop ship the best product for their ailment.Cali, Colombia, June 04, 2020 (GLOBE NEWSWIRE) — View Systems, Inc.’s (VSYM), medical marijuana and hemp subsidiary, Sannabis S.A.S. (“the Company”) announces that in their first week of operation Dr. Sannabis has virtually seen over 58 patients in Colombia and is ramping up to over 100 patients per week. Dr. Sannabis are licensed physicians in Colombia that believe in the power of cannabis and can recommend the right treatment to patients by knowing their clinical history and seeing them using video conferencing.Currently in the U.S. and around the world, patients/customers are relying on sales clerks to recommend CBD and other cannabis derived products, and many times are “misdiagnosed” causing new customers to be discouraged...

Continue reading

Algernon Receives U.S. FDA Clearance for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19

VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has received, on June 3rd, 2020, clearance from the U.S. FDA for its recently submitted Investigational New Drug (IND) application for its planned multinational Phase 2b/3 study of its re-purposed drug NP-120 (Ifenprodil) as a potential therapeutic treatment for patients with COVID-19. Ifenprodil is an NMDA receptor antagonist.The clinical study for Ifenprodil is entitled, “A Randomized Open Label Phase 2b/3 Study of the Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Confirmed COVID-19 Infected Hospitalized Patients.” As part of the multinational Phase 2b/3...

Continue reading

DIGITAL ALLY CLOSES $5.1 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

Lenexa, KS, June 04, 2020 (GLOBE NEWSWIRE) — Digital Ally, Inc. (DGLY) (the “Company”), which develops, manufactures and markets advanced video recording products for law enforcement, emergency management, fleet safety and security, today announced the closing of an underwritten public offering of 3,090,909 shares of its common stock at a price of $1.65 per share, for gross proceeds to the Company of approximately $5.1 million, before deducting underwriting discounts and other offering expenses. The Company intends to use the net proceeds from this offering for working capital, product development, order fulfillment and for general corporate purposes.In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 463,636 shares of common stock offered in the public offering to cover over-allotments,...

Continue reading

Agricultural Biologicals Market Size, COVID19 Impact Analysis, Industry Growth, Forecast 2019-2026 | Says Fortune Business Insights™

Pune, June 04, 2020 (GLOBE NEWSWIRE) — The global agricultural biologicals industry is expected to witness prominent growth in the coming year son account of the increasing need to feed the growing population with better quality agrarian production. The rising incidences of pest outbreaks destroy fields at a stretch in no time. Many farmers face huge losses every year. Pesticides and chemicals used in crops are harmful to humans when consumed, and this led to the adoption of biologicals. A recent report by Fortune Business Insights titled, “Agricultural Biologicals Market Size, Share and Industry Analysis By Type (Biopesticides, Biostimulants, and Biofertilizers), Source (Microbial and Biochemicals), Application Method (Foliar Spray, Soil Treatment, Seed Treatment, and Others), By Crops, and Regional Forecast 2019-2026,” states...

Continue reading

SmartCard Marketing Systems Inc. (OTC:SMKG) Announces Genorocity API Sandbox Release for Private (Closed-loop) Virtual Card Issuing, Processing & Settlement Integration for Point-of-Sale Solutions & Payment Gateways

New York, NY, June 04, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SmartCard Marketing Systems Inc. (OTC:SMKG):Global Payments Industry:The payment industry is challenged by the lack of products or applications that can handle the payment process throughout the ecosystem with multiple channels and capabilities of supporting various types of integrations requiring routing to specific Hosts or Switches.Solution: The solution we offer creates a unique global opportunity providing a niche solution for Issuing and Routing of transaction authorizations to our Host configuration from the Point-of-Sale and Customers Wallet with any payment gateway. This allows seamless integration of our private or close-loop virtual card schemes integration with popular Point-of-Sale solution providers and payment gateways, further enabling merchants...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.